¡Activa las notificaciones laborales por email!
Genera un currículum adaptado en cuestión de minutos
Consigue la entrevista y gana más. Más información
Join a pioneering company in genetic medicines as a Scientist in Analytical Development. This role is crucial for developing and implementing analytical methods that ensure the quality and efficacy of innovative AAV-based gene therapies. You will collaborate with cross-functional teams, utilizing cutting-edge techniques to drive product development and regulatory success. With a focus on continuous learning and innovation, this position offers the chance to make a significant impact on the lives of patients with rare diseases. If you're passionate about biotechnology and eager to contribute to groundbreaking research, this opportunity is for you.
SpliceBio is a genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes. SpliceBio’s lead program, SB-007, targets the root cause of Stargardt disease – a genetic eye disease that causes blindness in children and adults – and is expected to enter clinical trials in 2025. SpliceBio’s pipeline includes additional gene therapy programs across therapeutic areas, including ophthalmology and neurology. Its proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein, protein splicing, and protein engineering research.
Founded in 2020, SpliceBio has rapidly established itself as a leader in the field. In 2022, the company raised a $57M series A financing – the largest in the history of Spanish biotechnology – led by UCB Ventures, Ysios Capital, NEA, Novartis Venture Fund, Gilde Healthcare and Asabys. This milestone was followed in 2023 by a strategic partnership with Spark Therapeutics (Roche) to develop a novel gene therapy for an undisclosed inherited retinal disorder. In 2024, the FDA granted IND clearance for SpliceBio’s lead program, SB-007, in Stargardt disease.
SpliceBio's international team operates from offices and labs in Barcelona (Parque Científico de Barcelona).
The Scientist in Analytical Development will play a critical role in the development and implementation of analytical methods to ensure the quality, safety, and efficacy of AAV-based gene therapies. The successful candidate will work collaboratively within both CMC and Translational functions by developing and validating assays for product development and regulatory submissions.
Master’s degree (M.S) in Biotechnology, Biochemistry, Molecular Biology, Analytical Chemistry, or a related field. PhD preferred but not mandatory. 2-5 years of industry experience in an analytical development role. Proven demonstrated expertise in bioassay development and hands-on experience with analytical techniques such as qPCR, dPCR, ELISA, Western Blot, flow cytometry, HPLC, and capillary electrophoresis, specifically for the characterization of viral vectors. Familiarity with statistical analysis tools and design of experiments (DOE). Experience in the validation of analytical methods in a GMP environment is highly desirable. Strong problem-solving capabilities, with the ability to troubleshoot complex technical challenges effectively. Exceptional attention to detail, ensuring accurate and thorough documentation in compliance with regulatory standards. Proficiency in authoring technical documents, presenting data to cross-functional teams, and preparing detailed reports. Ability to manage multiple projects, prioritize tasks, and deliver results in a fast-paced, dynamic environment. Fluent in Spanish and in English (both written and spoken).
Why joining Splice Bio? At Splice Bio, you will be part of a dynamic team dedicated to making a meaningful impact in the lives of patients with rare diseases. We offer a collaborative and inclusive environment where innovation is encouraged, and your contributions will make a direct impact on the success and growth of the company. We also offer competitive compensation, comprehensive benefits, and opportunities for professional growth in an expanding field.